21-May-2007

Quarterly Report



MANAGEMENT'S DISCUSSION AND ANALYSIS OR PLAN OF OPERATION
SPECIAL NOTE OF CAUTION REGARDING FORWARD-LOOKING STATEMENTS

Certain statements in this report, including statements in the following discussion which are not statements of historical fact, are what are known as "forward looking statements," which are basically statements about the future.
For that reason, these statements involve risk and uncertainty since no one can accurately predict the future. Words such as "plans," "intends," "will," "hopes," "seeks," "anticipates," "expects" and the like often identify such forward looking statements, but are not the only indication that a statement is a forward looking statement. Such forward looking statements include statements concerning our plans and objectives with respect to the present and future operations of the Company, and statements which express or imply that such present and future operations will or may produce revenues, income or profits.
Numerous factors and future events could cause the Company to change such plans and objectives or fail to successfully implement such plans or achieve such objectives, or cause such present and future operations to fail to produce revenues, income or profits. Therefore, the reader is advised that the following discussion should be considered in light of the discussion of risks and other factors contained in this report on Form 10-QSB and in the Company's other filings with the Securities and Exchange Commission. No statements contained in the following discussion should be construed as a guarantee or assurance of future performance or future results.

Management's Discussion and Analysis of Financial Condition and Results of Operations

Melo Biotechnology Holdings Inc., ("We," the "Company," or "Melo") a Canadian corporation formerly known as MIAD Systems Ltd., ("MIAD") was formed in March 1993 and began operating its business at that time. We were initially established as a full-line supplier of business computer systems as well as a provider of computer warranty, maintenance, installation and networking services; we did not sell to individuals. We provided these goods and services to our major clients who are primarily engaged in the corporate, institutional, municipal, utilities and education fields, typically as part of their computer networks.

On October 1, 2006, we formed a wholly-owned subsidiary, Melo Biotechnology Limited ("Melo Limited"), a British Virgin Islands corporation, to engage in the sales of health products throughout Hong Kong and China (the "Territory").
Through Melo Limited, we engage in the sale of dietary nutritional supplements in the Territory. Melo Limited purchases nutritional supplements from manufacturers and distributors and then distributes the products to certain sales agents in the Territory who market the products to different vendors.
Melo Limited has an established office in Hong Kong. Melo Limited

21 -5月- 2 007年

季度报告



管理层的讨论与分析或行动计划
特别注意的关于前瞻性声明

某些陈述在这份报告中的陈述，包括在随后的讨论中不属于历史事实的陈述，是所谓的"前瞻性陈述" ，这是一种基本的声明对未来充满信心。
出于这个原因，这些陈述涉及到风险和不确定性，因为没有人能准确地预测未来。词语，如"计划" ， "打算" ， "将要" ， "希望" ， "寻求" ， "预期" ， "预计"等，也往往找出这些前瞻性声明，但不是唯一的迹象表明，声明前瞻性声明。这种前瞻性陈述包括关于我们的计划和目标，针对当前和未来的作战中，该公司和报表，其中明示或暗示这种目前和未来的业务将或可能产生的收入，收入或利润。
诸多因素及未来发生的事件可能会导致该公司为了改变这种计划和目标或未能成功地实施这样的计划或达到这样的目标，或导致当前和未来的作战中，以不产生收入，收入或利润。因此，请读者表示，经讨论后，应考虑根据讨论的风险和其他因素，包含在这份报告中的表10 - qsb并在该公司的另一家提交给美国证券交易委员会的文件。没有报表所载在随后的讨论中应被视为担保或保证今后的业绩或未来的结果。

管理层的讨论与分析财务状况和经营业绩的

甜瓜生物科技集团股份有限公司（简称"我们" ， "公司"或"甜瓜" ）的加拿大公司，以前称为miad系统有限公司， （下称" miad " ）成立于1993年3月开始运作，其业务当时。我们初步建立了作为一个全系列供应商的商业计算机系统，以及提供电脑保修，维修，安装和网络服务，我们没有出售给个人。我们提供的这些商品和服务，以我们的大客户，他们主要从事公司，机构，市政管理，公用事业和教育等领域，通常将其作为计算机网络上进行。

于2006年10月1日，我们专门成立了一家全资附属公司，甜瓜生物技术有限公司（简称"甜瓜有限公司" ） ，英属维尔京群岛的公司，从事销售的健康产品在整个香港和中国（ "领土" ） 。
通过甜瓜有限，但我们搞销售的膳食营养补充剂在该领土。甜瓜有限公司购买营养补充品，从制造商和分销商，然后分销产品，以一定的销售代理商在境内市场的产品，以不同的供应商。
甜瓜有限公司已是一个在香港设有办事处。甜瓜有限公司